| 000 | 01003 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250518040448.0 | ||
| 264 | 0 | _c20191111 | |
| 008 | 201911s 0 0 eng d | ||
| 022 | _a2167-9223 | ||
| 024 | 7 |
_a10.1080/21678421.2019.1582672 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGenge, Angela | |
| 245 | 0 | 0 |
_aEdaravone administration in pivotal clinical Study 19. _h[electronic resource] |
| 260 |
_bAmyotrophic lateral sclerosis & frontotemporal degeneration _c05 2019 |
||
| 300 |
_a298-299 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Research Support, Non-U.S. Gov't; Comment | ||
| 650 | 0 | 4 | _aAmyotrophic Lateral Sclerosis |
| 650 | 0 | 4 | _aAntipyrine |
| 650 | 0 | 4 | _aEdaravone |
| 650 | 0 | 4 | _aFree Radical Scavengers |
| 650 | 0 | 4 | _aHumans |
| 700 | 1 | _aBrooks, Benjamin | |
| 773 | 0 |
_tAmyotrophic lateral sclerosis & frontotemporal degeneration _gvol. 20 _gno. 3-4 _gp. 298-299 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/21678421.2019.1582672 _zAvailable from publisher's website |
| 999 |
_c29681299 _d29681299 |
||